PARAMETER OPTIMIZATION AND VIRTUAL SCREENING INDONESIAN HERBAL DATABASE AS HUMAN IMMUNODEFICIENCY VIRUS -1 INTEGRASE INHIBITOR USING AUTODOCK AND VINA
Keywords:Virtual Screening, Indonesian Natural Product, Human immunodeficiency virus-1 integrase, Molecular docking
Objective: Human immunodeficiency virus (HIV-1) is a virus that causes acquired immunodeficiency syndrome, a disease considered to be one of the
most dangerous because of its high mortality, morbidity, and infectivity. The emergence of mutant HIV strains has led treatment to target protease
as reverse transcriptase and integrase enzyme become less effective. This study aims to provide knowledge about the potential of HIV-1 integrase
inhibitors for use as guiding compounds in the development of new anti-HIV drugs.
Methods: This study used AutoDock and AutoDock Vina for virtual screening of the Indonesian herbal database for inhibitors of HIV-1 integrase and
is validated using a database of the directory of useful decoys. Optimization was accomplished by selecting the grid size, the number of calculations,
and the addition of two water molecules and a magnesium atom as cofactor.
Results: This study determined that the best grid box size is 21.1725Ã—21.1725Ã—21.1725 in unit space size (1 unit space equals to macromolecules 1Çº),
using AutoDock Vina with EF and AUC values, 3.93 and 0.693, respectively. Three important water molecules have meaning in molecular docking
around the binding pocket.
Conclusions: This study obtained the top ten ranked compounds using AutoDock Vina. The compounds include: Casuarinin; Myricetin-3-O-(2'',6''-
di-O-Î±-rhamnosyl)-Î²-glucoside; 5,7,2',4'-tetrahydroxy-6,3'-diprenylisoflavone 5-O-(4''-rhamnosylrhamnoside); myricetin 3-robinobioside; cyanidin
3-[6-(6-ferulylglucosyl)-2-xylosylgalactoside]; mesuein, cyanidin 7-(3-glucosyl-6-malonylglucoside)-4'-glucoside; kaempferol 3-[glucosyl-(1â†’3)-
rhamnosyl-(1â†’6)-galactoside]; 3-O-galloylepicatechin-(4-Î²â†’8)-epicatechin-3-O-gallate; and quercetin 4'-glucuronide.
Radji M. Immunology and Virology. 1st ed. Jakarta: PT ISFI Penerbitan;
National AIDS Committee. World HIV/ AIDS Day 2013: Protect
Workers, Families, and Nation; 2013.
Adesokan AA, Roberts VA, Lee KW, Lins RD, Briggs JM. Prediction
of HIV-1 integrase/viral DNA interactions in the catalytic domain by
fast molecular docking. J Med Chem 2004;47(4):821-8.
Xiong J. Essential Bioinformatics. New York: Cambridge University
Ghosh AK, Dawson ZL, Mitsuya H. Darunavir, a conceptually new
HIV-1 protease inhibitor for the treatment of drug-resistant HIV. Bioorg
Med Chem 2007;15(24):7576-80.
Syahdi RR. Virtual Screening of Indonesian Herbal Database as
HIV-1 Enzymes Inhibitors. Depok: Fakultas Matematika dan Ilmu
Pengetahuan Alam Universitas Indonesia; 2011.
Huang N, Shoichet BK, Irwin JJ. Benchmarking sets for molecular
docking. J Med Chem 2006;49(23):6789-801.
Wallach I, Lilien R. Virtual decoy sets for molecular docking
benchmarks. J Chem Inf Model 2011;51(2):196-202.
Lyons T, Fisher L, Varma S, Chen D. Creating a Smart Virtual Screening
Protocol, Part 1: Preparing the Target Protein. San Diego: Accelrys; 2005.
Bender A, Glen RC. A discussion of measures of enrichment in virtual
screening: Comparing the information content of descriptors with
increasing levels of sophistication. J Chem Inf Model 2005;45(5):1369-75.
Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. Directory of useful
decoys, enhanced (DUD-E): Better ligands and decoys for better
benchmarking. J Med Chem 2012;55(4):6582-94.
Fawcett T. An introduction to ROC analysis. Pattern Recognit
Yanuar A. Molecular tethering: Practices and applications on virtual
screening. Depok: Fakultas Farmasi Universitas Indonesia; 2012.